IRIS Accounts Production v25.1.3.33 06760581 Board of Directors 1.9.23 31.8.24 31.8.24 false true false false false true false Ordinary Shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh067605812023-08-31067605812024-08-31067605812023-09-012024-08-31067605812022-08-31067605812022-09-012023-08-31067605812023-08-3106760581ns14:PoundSterling2023-09-012024-08-3106760581ns10:Director12023-09-012024-08-3106760581ns10:PrivateLimitedCompanyLtd2023-09-012024-08-3106760581ns10:SmallEntities2023-09-012024-08-3106760581ns10:AuditExempt-NoAccountantsReport2023-09-012024-08-3106760581ns10:SmallCompaniesRegimeForDirectorsReport2023-09-012024-08-3106760581ns10:SmallCompaniesRegimeForAccounts2023-09-012024-08-3106760581ns10:FullAccounts2023-09-012024-08-310676058112023-09-012024-08-3106760581ns10:OrdinaryShareClass12023-09-012024-08-3106760581ns10:Director22023-09-012024-08-3106760581ns10:CompanySecretary12023-09-012024-08-3106760581ns10:RegisteredOffice2023-09-012024-08-3106760581ns5:CurrentFinancialInstruments2024-08-3106760581ns5:CurrentFinancialInstruments2023-08-3106760581ns5:Non-currentFinancialInstruments2024-08-3106760581ns5:Non-currentFinancialInstruments2023-08-3106760581ns5:ShareCapital2024-08-3106760581ns5:ShareCapital2023-08-3106760581ns5:RetainedEarningsAccumulatedLosses2024-08-3106760581ns5:RetainedEarningsAccumulatedLosses2023-08-3106760581ns5:NetGoodwill2023-09-012024-08-3106760581ns5:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3106760581ns5:NetGoodwill2023-08-3106760581ns5:NetGoodwill2024-08-3106760581ns5:NetGoodwill2023-08-3106760581ns5:PlantMachinery2023-08-3106760581ns5:PlantMachinery2023-09-012024-08-3106760581ns5:PlantMachinery2024-08-3106760581ns5:PlantMachinery2023-08-3106760581ns5:WithinOneYearns5:CurrentFinancialInstruments2024-08-3106760581ns5:WithinOneYearns5:CurrentFinancialInstruments2023-08-3106760581ns10:OrdinaryShareClass12024-08-3106760581ns5:RetainedEarningsAccumulatedLosses2023-08-3106760581ns5:RetainedEarningsAccumulatedLosses2023-09-012024-08-31
REGISTERED NUMBER: 06760581















Unaudited Financial Statements for the Year Ended 31 August 2024

for

Dr I Paraskevopoulos Limited

Dr I Paraskevopoulos Limited (Registered number: 06760581)






Contents of the Financial Statements
for the Year Ended 31 August 2024




Page

Company Information 1

Balance Sheet 2 to 3

Notes to the Financial Statements 4 to 6


Dr I Paraskevopoulos Limited

Company Information
for the Year Ended 31 August 2024







DIRECTORS: Dr I Paraskevopoulos
Mrs M A Paraskevopoulos





SECRETARY: Mrs M A Paraskevopoulos





REGISTERED OFFICE: Suite 1
Concept House
23 Billet Lane
Hornchurch
Essex
RM11 1XP





REGISTERED NUMBER: 06760581





ACCOUNTANTS: Havard & Associates
Suite 1
Concept House
23 Billet Lane
Hornchurch
Essex
RM11 1XP

Dr I Paraskevopoulos Limited (Registered number: 06760581)

Balance Sheet
31 August 2024

31.8.24 31.8.23
Notes £    £    £   
FIXED ASSETS
Intangible assets 4 5,277 26,382
Tangible assets 5 38,955 48,496
44,232 74,878

CURRENT ASSETS
Stocks 3,500 3,000
Debtors 6 12,407 4,317
Cash at bank 274,190 273,191
290,097 280,508
CREDITORS
Amounts falling due within one year 7 84,132 66,965
NET CURRENT ASSETS 205,965 213,543
TOTAL ASSETS LESS CURRENT
LIABILITIES

250,197

288,421

CREDITORS
Amounts falling due after more than one
year

8

(7,043

)

(28,093

)

PROVISIONS FOR LIABILITIES (10,379 ) (10,379 )
NET ASSETS 232,775 249,949

CAPITAL AND RESERVES
Called up share capital 9 2 2
Retained earnings 10 232,773 249,947
SHAREHOLDERS' FUNDS 232,775 249,949

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Dr I Paraskevopoulos Limited (Registered number: 06760581)

Balance Sheet - continued
31 August 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 April 2025 and were signed on its behalf by:





Dr I Paraskevopoulos - Director


Dr I Paraskevopoulos Limited (Registered number: 06760581)

Notes to the Financial Statements
for the Year Ended 31 August 2024

1. STATUTORY INFORMATION

Dr I Paraskevopoulos Limited is a private company, limited by shares , registered in Not specified/Other. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Amortisation is provided at the following rate in order to write off the goodwill over its estimated useful life:

10% straight line.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following rates in order to write off each asset over its estimated useful life:

Fixtures & fittings - 20% reducing value.
Plant & machinery - 20% reducing value.
Computer equipment - 33.33% straight line.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Dr I Paraskevopoulos Limited (Registered number: 06760581)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2024

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 September 2023
and 31 August 2024 211,051
AMORTISATION
At 1 September 2023 184,669
Charge for year 21,105
At 31 August 2024 205,774
NET BOOK VALUE
At 31 August 2024 5,277
At 31 August 2023 26,382

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 September 2023 160,826
Additions 719
At 31 August 2024 161,545
DEPRECIATION
At 1 September 2023 112,330
Charge for year 10,260
At 31 August 2024 122,590
NET BOOK VALUE
At 31 August 2024 38,955
At 31 August 2023 48,496

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.24 31.8.23
£    £   
Other debtors 12,407 4,317

Dr I Paraskevopoulos Limited (Registered number: 06760581)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.24 31.8.23
£    £   
Bank loans and overdrafts 21,000 21,000
Taxation and social security 26,124 45,551
Other creditors 37,008 414
84,132 66,965

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.8.24 31.8.23
£    £   
Bank loans 7,043 28,093

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.8.24 31.8.23
value: £    £   
2 Ordinary Shares £1 2 2

10. RESERVES
Retained
earnings
£   

At 1 September 2023 249,947
Profit for the year 54,826
Dividends (72,000 )
At 31 August 2024 232,773

11. PURCHASE OF TUDDENT LIMITED

The trade assets and all liabilities of Tuddent Limited, now dissolved, were acquired by Dr I Paraskevopoulos on 24 th September 2015. The two companies were under 100% common control and accordingly the transfer is effected under s.940A CTA 2010.

The assets acquired under s.940A CTA 2010 and accordingly the acquisition value is the written down value of the assets of Tuddent limited at the transfer date under s.948 (2).